Chadi Nabhan: ASCO and Ryght AI Collaborate on Breast Cancer Clinical Trial Site Selection
The media is framing this as 'innovation in oncology,' using buzzwords like 'collaboration' and 'AI-driven precision' to mask the commercialization of medical research.
This is a data grab disguised as scientific progress. ASCO provides the institutional legitimacy, while Ryght AI provides the black-box algorithm to gatekeep which hospitals get lucrative clinical trial funding. We are looking at a potential multi-million dollar licensing agreement where $50M in pharmaceutical research grants will be funneled only through sites that satisfy Ryght's proprietary metrics.
The media is framing this as 'innovation in oncology,' using buzzwords like 'collaboration' and 'AI-driven precision' to mask the commercialization of medical research.
This is a data grab disguised as scientific progress. ASCO provides the institutional legitimacy, while Ryght AI provides the black-box algorithm to gatekeep which hospitals get lucrative clinical trial funding. We are looking at a potential multi-million dollar licensing agreement where [REDACTED:$50M in pharmaceutical research grants] will be funneled only through sites that satisfy Ryght's proprietary metrics.
◀ Left-Leaning Frame
Left-leaning outlets will celebrate the 'democratization of healthcare through tech,' while ignoring how these algorithms likely bake in existing socioeconomic biases that favor wealthy, urban hospital systems.
Right-Leaning Frame ▶
Right-leaning outlets will laud the 'efficiency of private sector innovation,' while conveniently overlooking the consolidation of power within a few massive, unaccountable tech-medical conglomerates.
Ryght AI (valuation boost), ASCO (new revenue stream via partnership fees), and Big Pharma contractors who can afford the high entry costs of these 'optimized' trial sites.
The lack of transparency regarding the training data used by Ryght AI, which could lead to algorithmic bias in patient selection that is shielded from public audit by intellectual property laws.
⚠ This analysis is AI-generated speculation. Verify all claims independently. Trust no single source — including us.